In the US, COVID-19 has unveiled a disproportionate health burden in low income and underserved segments of society. In Louisiana, some of the greatest health and economic consequences are evident in our Black communities. There is an urgent need to establish effective testing strategies in these communities as the Fall/Winter virus surges unfold. The Louisiana Clinical and Translational Science (LA CaTS) Center provides the essential infrastructure and key foundational support for biomedical research in our region and is uniquely positioned to lead a community-engaged testing research project to determine differences in COVID-19 testing rates between community-based (churches, community centers, and schools) and medical clinic-based testing sites, and determine approaches that will increase uptake of testing in underserved Black communities in the South. We plan to address these issues using a two-pronged approach. First, we will use a community based participatory research approach to determine differences in SARS-CoV-2 testing rates across distinct types of test sites within five urban underserved Black communities in the American South. We will use a multimedia campaign to promote and conduct RT-PCR testing on salivary samples obtained from 2,000 adults at 1) medical clinics, 2) schools, 3) community centers, and 4) churches (in random order) within five ZIP codes with known low socioeconomic status (SES) and a high representation of Black residents. The primary outcome will be the number of tests performed at each type of test site. We will collect information on age, sex, race, BMI, employment, social determinants of health using an aggregate SES score to identify important correlates of testing rates. Second, we will further leverage our strong and well-integrated partnership with the Baton Rouge Mayor's Healthy City Initiative together with our LA CaTS Community Advisory Boards (CABs) to conduct community-based focus groups to obtain qualitative data about the perceptions and attitudes related to testing access and potential barriers affecting such. We will use this information to determine community-driven approaches that are effective in reducing barriers and create strategies to increase SARS-CoV-2 testing uptake in urban underserved Black communities. Results of this project will greatly increase our understanding of the factors that have led to a disproportionate COVID-19 health burden in these underserved populations and lay the groundwork for developing strategies to reduce these disparities in all underserved Black communities. Resulting data will inform the equitable deployment of future virus/flu testing and a SARS-CoV-2 vaccine.

Public Health Relevance

To date, there has been relatively limited success in implementing COVID-19 testing in large segments of the population, particularly in low income underserved Black communities who concomitantly carry a disproportionate burden of health disparity. The proposed project will determine the best strategy to conduct culturally sensitive COVID-19 testing for urban underserved Black communities in the South. This project will significantly increase our understanding of how to successfully deploy resources that will maximize participation in COVID-19 testing in poor urban underserved Black communities and will lay the groundwork for developing policies to carry out future virus testing and vaccination programs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54GM104940-05S3
Application #
10258534
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Gao, Hongwei
Project Start
2020-11-17
Project End
2022-06-30
Budget Start
2020-11-17
Budget End
2021-06-30
Support Year
5
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Lsu Pennington Biomedical Research Center
Department
Type
Organized Research Units
DUNS #
611012324
City
Baton Rouge
State
LA
Country
United States
Zip Code
70808
Boule, Lisbeth A; Ju, Cynthia; Agudelo, Marisela et al. (2018) Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol 66:35-43
Heerman, William J; Bennett, Wendy L; Kraschnewski, Jennifer L et al. (2018) Willingness to participate in weight-related research as reported by patients in PCORnet clinical data research networks. BMC Obes 5:10
Marlatt, Kara L; Beyl, Robbie A; Redman, Leanne M (2018) A qualitative assessment of health behaviors and experiences during menopause: A cross-sectional, observational study. Maturitas 116:36-42
Serrano-Gómez, Silvia J; Fejerman, Laura; Zabaleta, Jovanny (2018) Breast Cancer in Latinas: A Focus on Intrinsic Subtypes Distribution. Cancer Epidemiol Biomarkers Prev 27:3-10
Broskey, Nicholas T; Obanda, Diana N; Burton, Jeffrey H et al. (2018) Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes. Metabolism 82:118-123
Staiano, Amanda E; Webster, Elizabeth Kipling; Allen, Andrew T et al. (2018) Screen-Time Policies and Practices in Early Care and Education Centers in Relationship to Child Physical Activity. Child Obes 14:341-348
Hawkins, Keely R; Burton, Jeffrey H; Apolzan, John W et al. (2018) Efficacy of a school-based obesity prevention intervention at reducing added sugar and sodium in children's school lunches: the LA Health randomized controlled trial. Int J Obes (Lond) 42:1845-1852
Marlatt, Kara L; White, Ursula A; Beyl, Robbie A et al. (2018) Role of resistant starch on diabetes risk factors in people with prediabetes: Design, conduct, and baseline results of the STARCH trial. Contemp Clin Trials 65:99-108
Hossain, Fokhrul; Majumder, Samarpan; Ucar, Deniz A et al. (2018) Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses. Front Immunol 9:1288
Peaceman, Alan M; Clifton, Rebecca G; Phelan, Suzanne et al. (2018) Lifestyle Interventions Limit Gestational Weight Gain in Women with Overweight or Obesity: LIFE-Moms Prospective Meta-Analysis. Obesity (Silver Spring) 26:1396-1404

Showing the most recent 10 out of 528 publications